electroCore (ECOR) Change in Receivables (2017 - 2026)
electroCore's (ECOR) quarterly Change in Receivables came in at -$147000.0 in Q1 2026, down 301.37% year-on-year from $73000.0 in Q1 2025, and up 67.69% quarter-over-quarter from -$455000.0 in Q4 2025.
electroCore (ECOR) Change in Receivables (2017 - 2026) Analysis & Trends
electroCore's Change in Receivables history runs 10 years deep, the most recent figure standing at -$147000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables fell 301.37% year-over-year to -$147000.0 in Q1 2026; TTM through Mar 2026 was -$78000.0, a 107.61% decrease from a year earlier, with the FY2025 full-year figure at $142000.0, down 80.0% from the prior year.
- Change in Receivables climbed to -$147000.0 in Q1 2026 per ECOR's latest filing, from -$455000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $875000.0 in Q4 2024 and bottomed at -$455000.0 in Q4 2025.
- The 5-year median for Change in Receivables is $21000.0 (2023), against an average of $54705.9.
- Across the five-year window, Change in Receivables tumbled 581.82% in 2022 and soared 4257.14% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $37000.0 in 2022, then plunged by 43.24% to $21000.0 in 2023, then surged by 4066.67% to $875000.0 in 2024, then sank by 152.0% to -$455000.0 in 2025, then jumped by 67.69% to -$147000.0 in 2026.
- Per Business Quant, the three latest ECOR Change in Receivables figures stand at -$147000.0 (Q1 2026), -$455000.0 (Q4 2025), and $610000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | - |
| 10 | electroCore | 55,240.01 | -8.77 Mn | 8.36 Mn | -147,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147,000.00 |
| Mar 31, 2026 | -147,000.00 |
| Dec 31, 2025 | -455,000.00 |
| Dec 31, 2025 | -455,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | -86,000.00 |
| Jun 30, 2025 | -86,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 875,000.00 |
| Dec 31, 2024 | 875,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Jun 30, 2024 | 63,000.00 |
| Mar 31, 2024 | -242,000.00 |
| Mar 31, 2024 | -242,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |